PATRICIA ALVAREZ: Open Payments
NPI 1578077038 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,088 in 65 payments from 14 companies in 2025. Trend: 2023 $925 · 2024 $513 · 2025 $1,088
Food & beverage: $1,088
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $200 |
| Lilly USA, LLC | 16 | $185 |
| AstraZeneca Pharmaceuticals LP | 3 | $167 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $158 |
| GlaxoSmithKline, LLC. | 13 | $138 |
| ARGENX US, INC. | 2 | $53 |
| ABBVIE INC. | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Dexcom, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $24 |
Products named: OTEZLA, BREZTRI, JARDIANCE, MOUNJARO, TRELEGY ELLIPTA, VYVGART, OFEV, DUPIXENT.
Industry payments across CA — which companies pay providers there.
